2010
Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route
Duan S, Shen S, Bulterys M, Jia Y, Yang Y, Xiang L, Tian F, Lu L, Xiao Y, Wang M, Jia M, Jiang H, Vermund SH, Jiang Y. Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route. BMC Public Health 2010, 10: 180. PMID: 20374618, PMCID: PMC2858119, DOI: 10.1186/1471-2458-10-180.Peer-Reviewed Original ResearchConceptsHIV incidenceDiscordant couplesHIV epidemicMajor drug trafficking routesRecent HIV-1 infectionAnnual HIV incidenceHIV-discordant couplesHIV-1 prevalenceHIV-1 incidenceHIV-1 infectionMigration of HIVFemale sex workersPre-marital couplesCross-sectional surveyBED IgGRecent seroconversionIntensive prevention measuresHIV-positivePregnant womenHIV preventionHigh riskResultsFrom 2004Drug usersMultivariate analysisEnzyme immunoassay
2009
[Evaluation of BED-CEIA assay with dried blood spot specimens in China].
Shen S, Tian F, Jiang HZ, Sun GQ, Miao LF, Guo XL, Xiao Y, Jia YJ, Vermund SH, Jiang Y. [Evaluation of BED-CEIA assay with dried blood spot specimens in China]. Chinese Journal Of Epidemiology 2009, 30: 273-6. PMID: 19642385.Peer-Reviewed Original ResearchConceptsDBS specimensBED-CEIAHIV-1-positive specimensRecent HIV infectionHIV-1 incidencePositive controlHIV infectionHIV incidenceHIV-positiveVoluntary counselingIncidence rateCutoff valueLow positive controlPositive specimensPlasma specimensWindow periodConcordance rateBlood spotsWestern blotEligible pairsFurther studiesNegative controlDBSIncidenceTesting sites
2000
Network-related Mechanisms May Help Explain Long-term HIV-1 Seroprevalence Levels That Remain High but Do Not Approach Population-Group Saturation
Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des Jarlais DC. Network-related Mechanisms May Help Explain Long-term HIV-1 Seroprevalence Levels That Remain High but Do Not Approach Population-Group Saturation. American Journal Of Epidemiology 2000, 152: 913-922. PMID: 11092433, DOI: 10.1093/aje/152.10.913.Peer-Reviewed Original ResearchConceptsDrug injectorsSeroprevalence levelsHIV-1 incidenceHigh-risk subgroupsHuman immunodeficiency virusBehavioral risk reductionHigh prevalence situationsImmunodeficiency virusHigh seroprevalenceSeronegativesPrevention programsRisk behaviorsInfection outbreaksSeroprevalenceInfectious outbreaksMaximum incidenceSecondary outbreaksNetwork-based mechanismsRisk reductionIncidenceOutbreakOutbreak increasesNew York CityPrevalenceYork City